Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.
Saved in:
| Title: | Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines. |
|---|---|
| Authors: | Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Zhu H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK. Electronic address: henderson.zhu@paediatrics.ox.ac.uk., Silva-Reyes L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Blackwell L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Linder A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Bewley K; UKHSA Porton Down, Medical Interventions Group, Salisbury, Wiltshire, UK., Godwin K; UKHSA Porton Down, Medical Interventions Group, Salisbury, Wiltshire, UK., Fotheringham S; UKHSA Porton Down, Medical Interventions Group, Salisbury, Wiltshire, UK., Charlton S; UKHSA Porton Down, Medical Interventions Group, Salisbury, Wiltshire, UK., Kim YC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Rollier CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK; Section of Immunology, School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. |
| Source: | Vaccine [Vaccine] 2023 May 05; Vol. 41 (19), pp. 3047-3057. Date of Electronic Publication: 2023 Apr 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37037709 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dold+C%22">Dold C</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Zhu+H%22">Zhu H</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK. Electronic address: henderson.zhu@paediatrics.ox.ac.uk.<br /><searchLink fieldCode="AU" term="%22Silva-Reyes+L%22">Silva-Reyes L</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Blackwell+L%22">Blackwell L</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Linder+A%22">Linder A</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bewley+K%22">Bewley K</searchLink>; UKHSA Porton Down, Medical Interventions Group, Salisbury, Wiltshire, UK.<br /><searchLink fieldCode="AU" term="%22Godwin+K%22">Godwin K</searchLink>; UKHSA Porton Down, Medical Interventions Group, Salisbury, Wiltshire, UK.<br /><searchLink fieldCode="AU" term="%22Fotheringham+S%22">Fotheringham S</searchLink>; UKHSA Porton Down, Medical Interventions Group, Salisbury, Wiltshire, UK.<br /><searchLink fieldCode="AU" term="%22Charlton+S%22">Charlton S</searchLink>; UKHSA Porton Down, Medical Interventions Group, Salisbury, Wiltshire, UK.<br /><searchLink fieldCode="AU" term="%22Kim+YC%22">Kim YC</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Pollard+AJ%22">Pollard AJ</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Rollier+CS%22">Rollier CS</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK; Section of Immunology, School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2023 May 05; Vol. 41 (19), pp. 3047-3057. <i>Date of Electronic Publication: </i>2023 Apr 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37037709 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2023.04.012 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3047 Titles: – TitleFull: Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dold C – PersonEntity: Name: NameFull: Zhu H – PersonEntity: Name: NameFull: Silva-Reyes L – PersonEntity: Name: NameFull: Blackwell L – PersonEntity: Name: NameFull: Linder A – PersonEntity: Name: NameFull: Bewley K – PersonEntity: Name: NameFull: Godwin K – PersonEntity: Name: NameFull: Fotheringham S – PersonEntity: Name: NameFull: Charlton S – PersonEntity: Name: NameFull: Kim YC – PersonEntity: Name: NameFull: Pollard AJ – PersonEntity: Name: NameFull: Rollier CS IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 05 Text: 2023 May 05 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 41 – Type: issue Value: 19 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
